Ben Amar M (2006). «Cannabinoids in medicine: a review of their therapeutic potential». Journal of Ethnopharmacology105 (1–2): 1–25. doi:10.1016/j.jep.2006.02.001. PMID16540272.
Ben Amar M (2006). «Cannabinoids in medicine: a review of their therapeutic potential». Journal of Ethnopharmacology105 (1–2): 1–25. doi:10.1016/j.jep.2006.02.001. PMID16540272.
Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND (2005). "Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors". Behavioural Brain Research 164 (2): 206–13. doi:10.1016/j.bbr.2005.06.021. PMID 16140402.
Carter GT, Rosen BS (2001). "Marijuana in the management of amyotrophic lateral sclerosis". The American Journal of Hospice & Palliative Care 18 (4): 264–70. doi:10.1177/104990910101800411. PMID 11467101.
Weydt P, Hong S, Witting A, Möller T, Stella N, Kliot M (2005). "Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 6 (3): 182–4. doi:10.1080/14660820510030149. PMID 16183560.
Ganon-Elazar E, Akirav I (2009). "Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance". J. Neurosci 29 (36): 11078–88. doi:10.1523/JNEUROSCI.1223-09.2009. PMID 19741114. Lay summary – PsychCentral (5 November 2009).
Patsos HA; Hicks DJ; Dobson RR; Greenhough, A; Woodman, N; Lane, JD; Williams, AC; Paraskeva, C (2005). "The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2". Gut 54 (12): 1741–50. doi:10.1136/gut.2005.073403. PMC 1774787. PMID 16099783.
Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM (2002). "Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia". Movement Disorders 17 (1): 145–9. doi:10.1002/mds.1280. PMID 11835452.
Di Carlo G, Izzo AA (2003). "Cannabinoids for gastrointestinal diseases: potential therapeutic applications". Expert Opinion on Investigational Drugs 12 (1): 39–49. doi:10.1517/13543784.12.1.39. PMID 12517253.
Lorente M; Carracedo A; Torres S; Natali, Francesco; Egia, Ainara; Hernández-Tiedra, Sonia; Salazar, María; Blázquez, Cristina et al. (2009). "Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis". Glia 57 (13): 1374–85. doi:10.1002/glia.20856. PMID 19229996.
Sylvestre DL, Clements BJ, Malibu Y (2006). "Cannabis use improves retention and virological outcomes in patients treated for hepatitis C". European Journal of Gastroenterology & Hepatology 18 (10): 1057–63. doi:10.1097/01.meg.0000216934.22114.51. PMID 16957511.
Powles T; te Poele R; Shamash J; Chaplin, T; Propper, D; Joel, S; Oliver, T; Liu, WM (2005). "Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway". Blood 105 (3): 1214–21. doi:10.1182/blood-2004-03-1182. PMID 15454482
Casanova ML; Blázquez C; Martínez-Palacio J; Villanueva, Concepción; Fernández-Aceñero, M. Jesús; Huffman, John W.; Jorcano, José L.; Guzmán, Manuel (2003). "Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors". The Journal of Clinical Investigation 111 (1): 43–50. doi:10.1172/JCI16116. PMC 151833. PMID 12511587.
Kreitzer AC, Malenka RC (2005). "Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models". Nature 445 (7128): 643–7. doi:10.1038/nature05506. PMID 17287809. Lay summary – Stanford University School of Medicine (7 February 2007).
^ Wilkinson, J. D.; Williamson, E. M. (2007). "Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis". Journal of Dermatological Science 45 (2): 87–92. doi:10.1016/j.jdermsci.2006.10.009. PMID 17157480.
Howard, J.; Anie, K. A.; Holdcroft, A.; Korn, S.; Davies, S. C. (2005). "Cannabis use in sickle cell disease: A questionnaire study". British Journal of Haematology 131 (1): 123–128. doi:10.1111/j.1365-2141.2005.05723.x. PMID 16173972
Singer HS (2005). "Tourette's syndrome: from behaviour to biology". Lancet Neurol 4 (3): 149–59. doi:10.1016/S1474-4422(05)01012-4. PMID 15721825.
Sandyk R, Awerbuch G (1988). "Marijuana and Tourette's syndrome". Journal of Clinical Psychopharmacology 8 (6): 444–5. doi:10.1097/00004714-198812000-00021. PMID 3235704.
Müller-Vahl KR, Kolbe H, Dengler R (1997). "Gilles de la Tourette syndrome. Effect of nicotine, alcohol and marihuana on clinical symptoms". Der Nervenarzt 68 (12): 985–9. PMID 9465342.